site:www.bioworld.com - Search Images

847 x 635 · png
www.bioworld.com
ASP-3082, a PROTAC that selectively degrades KRAS G12D protein, show…
847 x 635 · png
www.bioworld.com
Identification and development of a PET radiotracer for imaging α ...
847 x 635 · png
www.bioworld.com
RP-6306: a first-in-class, orally available and selective PKMYT1 ...
847 x 635 · png
www.bioworld.com
CD5-knockout anti-CD5 CAR T-cell product evaluated for relapsed and ...

847 x 635 · png
www.bioworld.com
Akero skyrockets on midstage data from NASH challenger efruxifermin ...
847 x 635 · png
www.bioworld.com
Factor XIa inhibitors from BMS/Janssen, Bayer show promise i…
847 x 635 · png
www.bioworld.com
HER2 exon 20 mutation inhibitor shows promise for the treatment of ...
847 x 635 · jpeg
www.bioworld.com
Skull bone composition plays important role in brain health | BioWorld

847 x 635 · png
www.bioworld.com
[64Cu]NOTA-UNC-PSMA-2 shows high tumor uptake and reduced accumulat…
847 x 635 · png
www.bioworld.com
Zebrafish model of Alagille syndrome supports role of Sox9 | BioWorld
847 x 635 · png
www.bioworld.com
RBD-4059, the first siRNA-based strategy targeting FXI, is ready for ...
847 x 635 · png
www.bioworld.com
Gene therapy ET-101 awarded orphan drug designation for ALS | BioWorld

847 x 635 · png
www.bioworld.com
Innate immunity can drive radiation-induced abscopal effect | BioWorld
847 x 635 · png
www.bioworld.com
GSK’s daprodustat cleared as first FDA-approved oral HIF-PHI in CKD ...
847 x 635 · png
www.bioworld.com
INCB-123667 shows efficacy in cyclin E-overexpressing tumor xenograft ...
847 x 635 · jpeg
www.bioworld.com
Shionogi’s oral COVID-19 antiviral wins full approval in Japan | BioWorld

847 x 635 · png
www.bioworld.com
Top-line results suggest Paradigm’s injectable Zilosul could be disease ...
847 x 635 · png
www.bioworld.com
ATF3 modulation found as an approach to treat hepatic steatosis | BioWorld
847 x 635 · jpeg
www.bioworld.com
Combining PD-L1 blockade with pharmacological HPK1 inhibition ove…
847 x 635 · jpeg
www.bioworld.com
Nexthera files IND application for NT-101 eye drop for wet AMD | BioWorld

847 x 635 · jpeg
www.bioworld.com
New mouse model of congenital fiber type disproportion | BioWorld
847 x 635 · png
www.bioworld.com
Boan Biotech nets almost $19.6M in Hong Kong IPO | BioWorld
847 x 635 · png
www.bioworld.com
Roche quits lung cancer phase II/III with anti-TIGIT tiragolumab | BioWorld
847 x 635 · png
www.bioworld.com
J&J aims for 2024 Ottava surgical robot trial approval | BioWorld

847 x 635 · jpeg
www.bioworld.com
MDNA-223, a novel anti-PD1-IL-2 BiSKIT candidate with efficacy in bot…
847 x 635 · png
www.bioworld.com
Orca Therapeutics presents new CA.GSK-3β-armed oncolytic virus wit…
847 x 635 · png
www.bioworld.com
LCK inhibitor NTRC-0652-0 shows synergy with EGFR inhibition in ...
847 x 635 · jpeg
www.bioworld.com
Adcendo licenses rights to Multitude’s ADC targeting tissue factor ...

847 x 635 · jpeg
www.bioworld.com
Discovery of TBA derivatives as potent HBV capsid assembly modulators ...
847 x 635 · png
www.bioworld.com
RAYZ-8009, a radiopharmaceutical therapy agent with efficacy in models ...
847 x 635 · png
www.bioworld.com
Apocalypse later? Lilly CRL for donanemab in AD no bombshell, pha…
847 x 635 · png
www.bioworld.com
Intron demonstrates inhibition of tumorigenesis using P18-BE3CRC in ...

847 x 635 · png
www.bioworld.com
Rgenta’s RGT-61159 cleared by FDA for first-in-human trial in adenoid ...
847 x 635 · jpeg
www.bioworld.com
Polyactiva’s ocular implant shows sustained drug delivery for glaucoma ...
847 x 635 · jpeg
www.bioworld.com
At CROI 2024, challenges and roads to new HIV vaccines | BioWorld

Some results have been hidden because they may be inaccessible to you.Show inaccessible results